Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study

AUTOR(ES)

Batista, José Gomes, Soares-Jr, José Maria, Maganhin, Carla Cristina, Simões, Ricardo Santos, Tomaz, Geraldez, Baracat, Edmund Chada

FONTE

Clinics

DATA DE PUBLICAÇÃO

2012

RESUMO

Documentos Relacionados

• PPARγ induces growth inhibition and apoptosis through upregulation of insulin-like growth factor-binding protein-3 in gastric cancer cells
• Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity*
• Enhancing the Apoptotic Potential of Insulin-Like Growth Factor-Binding Protein-3 in Prostate Cancer by Modulation of CK2 Phosphorylation
• Cycle modulation of insulin-like growth factor-binding protein 1 in human endometrium
• Cycle modulation of insulin-like growth factor-binding protein 1 in human endometrium